Normobaric Oxygen Therapy in Acute Ischemic Stroke
Author Information
Author(s): Padma M. V. Bhasin, A. Bhatia, R. Garg, A. Singh, M. B. Tripathi, M. Prasad
Primary Institution: All India Institute of Medical Sciences
Hypothesis
Can normobaric high-flow oxygen therapy improve outcomes in patients with acute ischemic stroke?
Conclusion
Normobaric oxygen therapy did not improve clinical scores of stroke outcome in Indian patients with acute ischemic stroke.
Supporting Evidence
- Patients receiving normobaric oxygen had a mean NIHSS score of 14.25 at admission, which decreased to 11.6 on the seventh day.
- The control group had a mean NIHSS score of 12.7 at admission, decreasing to 9.5 on the seventh day.
- Both groups showed improvement in mRS and BI scores over time, but no significant differences were found between groups.
Takeaway
The study tested if giving extra oxygen to stroke patients helps them get better, but it didn't show any real benefits.
Methodology
Patients with anterior circulation ischemic strokes were randomized to receive either normobaric oxygen or control treatment, with assessments made at multiple time points.
Potential Biases
Potential bias due to the small sample size and the inability to perform MRI on all patients.
Limitations
The study had a delay in starting oxygen therapy and used lower flow rates than previous studies, which may have affected the results.
Participant Demographics
Mean age of participants was 55.8 years, with a range from 26 to 82 years.
Statistical Information
P-Value
0.002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website